Literature DB >> 19107420

Strategies for the expression of SUMO-modified target proteins in Escherichia coli.

Hisato Saitoh1, Junsuke Uwada, Kawasaki Azusa.   

Abstract

We previously described the establishment of a binary vector system that allows co-expression of SUMO conjugation enzymes and a target protein of interest, leading to efficient SUMO modification and the production of a large amount of recombinant SUMO-modified proteins in Escherichia coli. The advantages of this E. coli expression/modification approach include scalability of experiments, low cost, fast growth, and a lack of proteases that cleave the isopeptide linkage between SUMO and the target protein. Thus, this E. coli method provides a useful alternative to authentic SUMO modification assays, such as in vitro SUMO conjugation and in vivo SUMO modification using baculovirus or mammalian cell culture, that are usually complicated, time-consuming and expensive.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19107420     DOI: 10.1007/978-1-59745-566-4_14

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  6 in total

1.  Caveolin-3 undergoes SUMOylation by the SUMO E3 ligase PIASy: sumoylation affects G-protein-coupled receptor desensitization.

Authors:  Stephen R Fuhs; Paul A Insel
Journal:  J Biol Chem       Date:  2011-03-01       Impact factor: 5.157

2.  Src SUMOylation Inhibits Tumor Growth Via Decreasing FAK Y925 Phosphorylation.

Authors:  Jing Wang; Rong Deng; Nan Cui; Hailong Zhang; Tianqi Liu; Jinzhuo Dou; Xian Zhao; Ran Chen; Yanli Wang; Jianxiu Yu; Jian Huang
Journal:  Neoplasia       Date:  2017-10-22       Impact factor: 5.715

3.  Fine-tuning of SUMOylation modulates drought tolerance of apple.

Authors:  Xuewei Li; Shuangxi Zhou; Zeyuan Liu; Liyuan Lu; Huan Dang; Huimin Li; Baohua Chu; Pengxiang Chen; Ziqing Ma; Shuang Zhao; Zhongxing Li; Steve van Nocker; Fengwang Ma; Qingmei Guan
Journal:  Plant Biotechnol J       Date:  2022-01-24       Impact factor: 13.263

4.  Recombinant receptor-binding domain of SARS-CoV spike protein expressed in mammalian, insect and E. coli cells elicits potent neutralizing antibody and protective immunity.

Authors:  Lanying Du; Guangyu Zhao; Chris C S Chan; Shihui Sun; Min Chen; Zhonghua Liu; Hongxiang Guo; Yuxian He; Yusen Zhou; Bo-Jian Zheng; Shibo Jiang
Journal:  Virology       Date:  2009-08-15       Impact factor: 3.616

5.  Modified recombinant proteins can be exported via the Sec pathway in Escherichia coli.

Authors:  Nan Chen; Fu-Lin Hong; Hai-Hong Wang; Qi-Hang Yuan; Wan-Yan Ma; Xu-Na Gao; Rui Shi; Rui-Juan Zhang; Chang-Sheng Sun; Sheng-Bin Wang
Journal:  PLoS One       Date:  2012-08-13       Impact factor: 3.240

Review 6.  Protective Immunity against SARS Subunit Vaccine Candidates Based on Spike Protein: Lessons for Coronavirus Vaccine Development.

Authors:  Atin Khalaj-Hedayati
Journal:  J Immunol Res       Date:  2020-07-18       Impact factor: 4.818

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.